MedPath

Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis

Phase 3
Completed
Conditions
Cerebral Palsy
Interventions
Biological: stem cell injection
Other: rehabilitation
Registration Number
NCT01929434
Lead Sponsor
General Hospital of Chinese Armed Police Forces
Brief Summary

Cerebral palsy (CP) is described as a group of permanent disorders affecting motor development and posture, resulting in activity limitation attributed to nonprogressive disturbances of the fetal or infant brain. The prevalence of cerebral palsy has increased among the children with low birth-weight, jaundice, respiratory distress and intrauterine infection and so on. The incidence of cerebral palsy is increasing gradually with increased neonatal survival rate. Although there are many kinds of functional therapy programs especially the rehabilitation treatment for cerebral palsy, their effects are limited. Increasing cerebral palsy patients become a heavy burden to the family and society. Stem cell based therapy, a new prospective therapy for central nervous system disorders, has the potential to repair the damaged brain tissue in patients with cerebral palsy.

In this study, 300 patients with cerebral palsy will be divided into three groups and the investigators will use mesenchymal stem cells derived from umbilical cord to treat 100 CP patients of them randomly. We will also follow up the other 100 patients who only receive rehabilitation treatment and another 100 patients who accept neither stem cell therapy nor rehabilitation treatment. On this basis, as the investigators we can compare the efficacy of cell therapy and rehabilitation treatments for cerebral palsy patients.

Multiple sources of assessment were used to ascertain and classify all cases of cerebral palsy. Particularly the Gross Motor Function Measure (GMFM) as an important valid and reliable outcome measure, has made it possible to evaluate the severity of movement disability,change over time and the effects of clinical interventions. It also will be the primary outcome measure in follow-up analysis of this study.

Detailed Description

Patients enrolled in this study need to finish our whole follow-up survey for 12 months, which is carried out by clinical doctors, rehabilitators and epidemiologist.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patients with diagnosis of cerebral palsy.
  • Patients' curator must be able to give voluntary consent.
Exclusion Criteria
  • Intracranial infection.
  • Severe respiratory and circulatory system diseases.
  • Hematologic malignancies.
  • Positive serological tests such as AIDS, hepatitis B virus, hepatitis C virus and syphilis (antigen or antibody).
  • Tumors.
  • Genetic and metabolic diseases.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
stem cell injectionstem cell injectionPatients in the group accept cell therapy including four times stem cells transplant via intrathecal injection.
rehabilitationrehabilitationPatients in the group accept rehabilitation for three weeks in hospital and other eleven months in their home under the guidance of physical therapist.
Primary Outcome Measures
NameTimeMethod
Gross Motor Function Measure ScoreChange from baseline at 12 monthes after enrollment or transplantation

Gross Motor Function Measure-88 and Gross Motor Function Measure-66

Secondary Outcome Measures
NameTimeMethod
Routine Blood Test and Biochemical TestChange from baseline at 12 monthes after enrollment or transplantation

1. red blood cell

2. white blood cell

3. platelet count

4. glutamic pyruvic transaminase

5. glutamic oxaloacetic transaminase

Trial Locations

Locations (1)

General Hospital of Chinese People's Armed Police Forces

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath